Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Mar 15;99(6):1179–1186. doi: 10.1172/JCI119274

Prolonged endothelin A receptor blockade attenuates chronic pulmonary hypertension in the ovine fetus.

D D Ivy 1, T A Parker 1, J W Ziegler 1, H L Galan 1, J P Kinsella 1, R M Tuder 1, S H Abman 1
PMCID: PMC507931  PMID: 9077525

Abstract

Based on past studies of an experimental model of severe intrauterine pulmonary hypertension, we hypothesized that endothelin-1 (ET-1) contributes to high pulmonary vascular resistance (PVR), hypertensive lung structural changes, and right ventricular hypertrophy (RVH) caused by prolonged closure of the ductus arteriosus. To test this hypothesis, we studied the effects of BQ 123, a selective ET(A) receptor antagonist, after ligation of the ductus arteriosus in utero. In 19 late gestation fetal lambs (126+/-3 d; 147 d, term) we ligated the ductus arteriosus at surgery, and treated animals with either BQ 123 (1 mg/d) or vehicle (0.1% DMSO, HTN) in the pulmonary artery for 8 d. Chronic BQ 123 treatment attenuated the rise in mean pulmonary artery pressure (PAP) 8 d after ductus arteriosus ligation (78+/-2, HTN vs. 70+/-4 mmHg, BQ 123, P < 0.05). To study the effects of ET(A) blockade at birth, 15 animals were delivered by cesarean section and ventilated with 10% oxygen (O2), 100% O2 and inhaled nitric oxide (NO). Lambs treated with BQ 123 had lower PVR after delivery during ventilation with 10% O2, 100% O2, and inhaled NO (HTN vs. BQ 123, P < 0.05 for each intervention). Acute BQ 123 treatment (2 mg/30 min) lowered PVR in three HTN animals ventilated with 100% O2 and inhaled NO (P < 0.05). Chronic BQ 123 treatment prevented the development of RVH as determined by the ratio of the right ventricle/left ventricle + septum (0.79+/-0.03, HTN vs. 0.57+/-0.06, BQ 123, P < 0.05) and attenuated the increase in wall thickness of small pulmonary arteries (61+/-2, HTN vs. 50+/-2%, BQ 123, P < 0.05). In summary, chronic intrauterine ET(A) receptor blockade decreased PAP in utero, decreased RVH and distal muscularization of small pulmonary arteries, and increased the fall in PVR at delivery. We conclude that ET(A) receptor stimulation contributes to the pathogenesis and pathophysiology of experimental perinatal pulmonary hypertension.

Full Text

The Full Text of this article is available as a PDF (272.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abman S. H., Shanley P. F., Accurso F. J. Failure of postnatal adaptation of the pulmonary circulation after chronic intrauterine pulmonary hypertension in fetal lambs. J Clin Invest. 1989 Jun;83(6):1849–1858. doi: 10.1172/JCI114091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Abman S. H., Wilkening R. B., Ward R. M., Accurso F. J. Adaptation of fetal pulmonary blood flow to local infusion of tolazoline. Pediatr Res. 1986 Nov;20(11):1131–1135. doi: 10.1203/00006450-198611000-00013. [DOI] [PubMed] [Google Scholar]
  3. Allen S. W., Chatfield B. A., Koppenhafer S. A., Schaffer M. S., Wolfe R. R., Abman S. H. Circulating immunoreactive endothelin-1 in children with pulmonary hypertension. Association with acute hypoxic pulmonary vasoreactivity. Am Rev Respir Dis. 1993 Aug;148(2):519–522. doi: 10.1164/ajrccm/148.2.519. [DOI] [PubMed] [Google Scholar]
  4. Belik J., Halayko A. J., Rao K., Stephens N. L. Fetal ductus arteriosus ligation. Pulmonary vascular smooth muscle biochemical and mechanical changes. Circ Res. 1993 Mar;72(3):588–596. doi: 10.1161/01.res.72.3.588. [DOI] [PubMed] [Google Scholar]
  5. Cacoub P., Dorent R., Maistre G., Nataf P., Carayon A., Piette C., Godeau P., Cabrol C., Gandjbakhch I. Endothelin-1 in primary pulmonary hypertension and the Eisenmenger syndrome. Am J Cardiol. 1993 Feb 15;71(5):448–450. doi: 10.1016/0002-9149(93)90452-i. [DOI] [PubMed] [Google Scholar]
  6. Cassin S., Kristova V., Davis T., Kadowitz P., Gause G. Tone-dependent responses to endothelin in the isolated perfused fetal sheep pulmonary circulation in situ. J Appl Physiol (1985) 1991 Mar;70(3):1228–1234. doi: 10.1152/jappl.1991.70.3.1228. [DOI] [PubMed] [Google Scholar]
  7. Chen S. J., Chen Y. F., Meng Q. C., Durand J., Dicarlo V. S., Oparil S. Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats. J Appl Physiol (1985) 1995 Dec;79(6):2122–2131. doi: 10.1152/jappl.1995.79.6.2122. [DOI] [PubMed] [Google Scholar]
  8. Coceani F., Kelsey L. Endothelin-1 release from lamb ductus arteriosus: relevance to postnatal closure of the vessel. Can J Physiol Pharmacol. 1991 Feb;69(2):218–221. doi: 10.1139/y91-033. [DOI] [PubMed] [Google Scholar]
  9. Giaid A., Yanagisawa M., Langleben D., Michel R. P., Levy R., Shennib H., Kimura S., Masaki T., Duguid W. P., Stewart D. J. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med. 1993 Jun 17;328(24):1732–1739. doi: 10.1056/NEJM199306173282402. [DOI] [PubMed] [Google Scholar]
  10. Hilal-Dandan R., Merck D. T., Lujan J. P., Brunton L. L. Coupling of the type A endothelin receptor to multiple responses in adult rat cardiac myocytes. Mol Pharmacol. 1994 Jun;45(6):1183–1190. [PubMed] [Google Scholar]
  11. Ito H., Hirata Y., Adachi S., Tanaka M., Tsujino M., Koike A., Nogami A., Murumo F., Hiroe M. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest. 1993 Jul;92(1):398–403. doi: 10.1172/JCI116579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ito H., Hirata Y., Hiroe M., Tsujino M., Adachi S., Takamoto T., Nitta M., Taniguchi K., Marumo F. Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res. 1991 Jul;69(1):209–215. doi: 10.1161/01.res.69.1.209. [DOI] [PubMed] [Google Scholar]
  13. Ito H., Hiroe M., Hirata Y., Fujisaki H., Adachi S., Akimoto H., Ohta Y., Marumo F. Endothelin ETA receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload. Circulation. 1994 May;89(5):2198–2203. doi: 10.1161/01.cir.89.5.2198. [DOI] [PubMed] [Google Scholar]
  14. Ivy D. D., Kinsella J. P., Abman S. H. Endothelin blockade augments pulmonary vasodilation in the ovine fetus. J Appl Physiol (1985) 1996 Dec;81(6):2481–2487. doi: 10.1152/jappl.1996.81.6.2481. [DOI] [PubMed] [Google Scholar]
  15. Ivy D. D., Kinsella J. P., Abman S. H. Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation. J Clin Invest. 1994 May;93(5):2141–2148. doi: 10.1172/JCI117210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ivy D. D., Ziegler J. W., Dubus M. F., Fox J. J., Kinsella J. P., Abman S. H. Chronic intrauterine pulmonary hypertension alters endothelin receptor activity in the ovine fetal lung. Pediatr Res. 1996 Mar;39(3):435–442. doi: 10.1203/00006450-199603000-00010. [DOI] [PubMed] [Google Scholar]
  17. Kaddoura S., Firth J. D., Boheler K. R., Sugden P. H., Poole-Wilson P. A. Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist. Circulation. 1996 Jun 1;93(11):2068–2079. doi: 10.1161/01.cir.93.11.2068. [DOI] [PubMed] [Google Scholar]
  18. Kanno K., Hirata Y., Tsujino M., Imai T., Shichiri M., Ito H., Marumo F. Up-regulation of ETB receptor subtype mRNA by angiotensin II in rat cardiomyocytes. Biochem Biophys Res Commun. 1993 Aug 16;194(3):1282–1287. doi: 10.1006/bbrc.1993.1962. [DOI] [PubMed] [Google Scholar]
  19. Kiowski W., Sütsch G., Hunziker P., Müller P., Kim J., Oechslin E., Schmitt R., Jones R., Bertel O. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet. 1995 Sep 16;346(8977):732–736. doi: 10.1016/s0140-6736(95)91504-4. [DOI] [PubMed] [Google Scholar]
  20. Komai H., Adatia I. T., Elliott M. J., de Leval M. R., Haworth S. G. Increased plasma levels of endothelin-1 after cardiopulmonary bypass in patients with pulmonary hypertension and congenital heart disease. J Thorac Cardiovasc Surg. 1993 Sep;106(3):473–478. [PubMed] [Google Scholar]
  21. Kourembanas S., McQuillan L. P., Leung G. K., Faller D. V. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest. 1993 Jul;92(1):99–104. doi: 10.1172/JCI116604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Levin D. L., Heymann M. A., Kitterman J. A., Gregory G. A., Phibbs R. H., Rudolph A. M. Persistent pulmonary hypertension of the newborn infant. J Pediatr. 1976 Oct;89(4):626–630. doi: 10.1016/s0022-3476(76)80405-2. [DOI] [PubMed] [Google Scholar]
  23. Lewis A. B., Heymann M. A., Rudolph A. M. Gestational changes in pulmonary vascular responses in fetal lambs in utero. Circ Res. 1976 Oct;39(4):536–541. doi: 10.1161/01.res.39.4.536. [DOI] [PubMed] [Google Scholar]
  24. Lippton H. L., Cohen G. A., McMurtry I. F., Hyman A. L. Pulmonary vasodilation to endothelin isopeptides in vivo is mediated by potassium channel activation. J Appl Physiol (1985) 1991 Feb;70(2):947–952. doi: 10.1152/jappl.1991.70.2.947. [DOI] [PubMed] [Google Scholar]
  25. Lock J. E., Hamilton F., Luide H., Coceani F., Olley P. M. Direct pulmonary vascular responses in the conscious newborn lamb. J Appl Physiol Respir Environ Exerc Physiol. 1980 Jan;48(1):188–196. doi: 10.1152/jappl.1980.48.1.188. [DOI] [PubMed] [Google Scholar]
  26. MacCumber M. W., Ross C. A., Glaser B. M., Snyder S. H. Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action. Proc Natl Acad Sci U S A. 1989 Sep;86(18):7285–7289. doi: 10.1073/pnas.86.18.7285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Miyauchi T., Yorikane R., Sakai S., Sakurai T., Okada M., Nishikibe M., Yano M., Yamaguchi I., Sugishita Y., Goto K. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ Res. 1993 Nov;73(5):887–897. doi: 10.1161/01.res.73.5.887. [DOI] [PubMed] [Google Scholar]
  28. Morin F. C., 3rd Ligating the ductus arteriosus before birth causes persistent pulmonary hypertension in the newborn lamb. Pediatr Res. 1989 Mar;25(3):245–250. doi: 10.1203/00006450-198903000-00005. [DOI] [PubMed] [Google Scholar]
  29. Murphy J. D., Rabinovitch M., Goldstein J. D., Reid L. M. The structural basis of persistent pulmonary hypertension of the newborn infant. J Pediatr. 1981 Jun;98(6):962–967. doi: 10.1016/s0022-3476(81)80605-1. [DOI] [PubMed] [Google Scholar]
  30. Nakamura T., Kasai K., Konuma S., Emoto T., Banba N., Ishikawa M., Shimoda S. Immunoreactive endothelin concentrations in maternal and fetal blood. Life Sci. 1990;46(15):1045–1050. doi: 10.1016/0024-3205(90)90412-k. [DOI] [PubMed] [Google Scholar]
  31. Rosenberg A. A., Kennaugh J., Koppenhafer S. L., Loomis M., Chatfield B. A., Abman S. H. Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension. J Pediatr. 1993 Jul;123(1):109–114. doi: 10.1016/s0022-3476(05)81552-5. [DOI] [PubMed] [Google Scholar]
  32. Tod M. L., Cassin S. Endothelin-1-induced pulmonary arterial dilation is reduced by N omega-nitro-L-arginine in fetal lambs. J Appl Physiol (1985) 1992 May;72(5):1730–1734. doi: 10.1152/jappl.1992.72.5.1730. [DOI] [PubMed] [Google Scholar]
  33. Vincent J. A., Ross R. D., Kassab J., Hsu J. M., Pinsky W. W. Relation of elevated plasma endothelin in congenital heart disease to increased pulmonary blood flow. Am J Cardiol. 1993 May 15;71(13):1204–1207. doi: 10.1016/0002-9149(93)90646-t. [DOI] [PubMed] [Google Scholar]
  34. Wagner O. F., Christ G., Wojta J., Vierhapper H., Parzer S., Nowotny P. J., Schneider B., Waldhäusl W., Binder B. R. Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem. 1992 Aug 15;267(23):16066–16068. [PubMed] [Google Scholar]
  35. Wang Y., Coceani F. Isolated pulmonary resistance vessels from fetal lambs. Contractile behavior and responses to indomethacin and endothelin-1. Circ Res. 1992 Aug;71(2):320–330. doi: 10.1161/01.res.71.2.320. [DOI] [PubMed] [Google Scholar]
  36. Wang Y., Coceani F. Isolated pulmonary resistance vessels from fetal lambs. Contractile behavior and responses to indomethacin and endothelin-1. Circ Res. 1992 Aug;71(2):320–330. doi: 10.1161/01.res.71.2.320. [DOI] [PubMed] [Google Scholar]
  37. Wang Y., Coe Y., Toyoda O., Coceani F. Involvement of endothelin-1 in hypoxic pulmonary vasoconstriction in the lamb. J Physiol. 1995 Jan 15;482(Pt 2):421–434. doi: 10.1113/jphysiol.1995.sp020529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Winters J. W., Wong J., Van Dyke D., Johengen M., Heymann M. A., Fineman J. R. Endothelin receptor blockade does not alter the increase in pulmonary blood flow due to oxygen ventilation in fetal lambs. Pediatr Res. 1996 Jul;40(1):152–157. doi: 10.1203/00006450-199607000-00026. [DOI] [PubMed] [Google Scholar]
  39. Wong J., Fineman J. R., Heymann M. A. The role of endothelin and endothelin receptor subtypes in regulation of fetal pulmonary vascular tone. Pediatr Res. 1994 Jun;35(6):664–670. doi: 10.1203/00006450-199406000-00008. [DOI] [PubMed] [Google Scholar]
  40. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988 Mar 31;332(6163):411–415. doi: 10.1038/332411a0. [DOI] [PubMed] [Google Scholar]
  41. Zamora M. A., Dempsey E. C., Walchak S. J., Stelzner T. J. BQ123, an ETA receptor antagonist, inhibits endothelin-1-mediated proliferation of human pulmonary artery smooth muscle cells. Am J Respir Cell Mol Biol. 1993 Oct;9(4):429–433. doi: 10.1165/ajrcmb/9.4.429. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES